Remove Clinical Research Remove Pharma Companies Remove Research Laboratories
article thumbnail

What will the 2023 drug discovery landscape look like?

Drug Discovery World

The researchers noted that such virtual trials incorporate numerous evidence-based assumptions regarding disease pathogenesis, therapeutic mechanism, side effects and a host of other factors which could impact the outcome. Quantifying the use of connected digital products in clinical research. The Lancet Oncology.

article thumbnail

BioSpace Movers & Shakers, Dec. 18

The Pharma Data

Martin Carter Professor in Clinical Investigation and Head of the Laboratory of Investigative Dermatology at The Rockefeller University and Weinblatt is the co-director of Clinical Rheumatology at the Brigham and Women’s Hospital. AB2 Bio – Swiss pharma company AB2 Bio Ltd. He spent 27 years at Merck & Co.